100 related articles for article (PubMed ID: 24375387)
1. Relationship between histologic response and the degree of tumor shrinkage after chemoradiotherapy in patients with locally advanced rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Saito G; Kamijo A; Akiba T; Kawada S
J Surg Oncol; 2014 Jun; 109(7):659-64. PubMed ID: 24375387
[TBL] [Abstract][Full Text] [Related]
2. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
[TBL] [Abstract][Full Text] [Related]
3. Prediction of histologic regression on the basis of colonoscopic findings in patients with locally advanced middle and lower rectal cancer who receive preoperative chemoradiotherapy.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Okamura H; Machida T
Tokai J Exp Clin Med; 2011 Dec; 36(4):100-5. PubMed ID: 22167490
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
5. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
6. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
7. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
[TBL] [Abstract][Full Text] [Related]
8. Barium enema and CT volumetry for predicting pathologic response to preoperative chemoradiotherapy in rectal cancer patients.
Murono K; Kawai K; Tsuno NH; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Dis Colon Rectum; 2014 Jun; 57(6):715-24. PubMed ID: 24807596
[TBL] [Abstract][Full Text] [Related]
9. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
[TBL] [Abstract][Full Text] [Related]
11. Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.
Kwak YK; Kim K; Lee JH; Kim SH; Cho HM; Kim DY; Kim TH; Kim SY; Baek JY; Oh JH; Nam TK; Yoon MS; Jeong JU; Chie EK; Jang HS; Kim JS
Radiother Oncol; 2016 Jun; 119(3):512-8. PubMed ID: 27106552
[TBL] [Abstract][Full Text] [Related]
12. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
13. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
[TBL] [Abstract][Full Text] [Related]
14. Failure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer.
Lim SB; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
J Surg Oncol; 2012 Nov; 106(6):667-73. PubMed ID: 22688948
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
[TBL] [Abstract][Full Text] [Related]
17. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
19. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer.
Patel UB; Brown G; Rutten H; West N; Sebag-Montefiore D; Glynne-Jones R; Rullier E; Peeters M; Van Cutsem E; Ricci S; Van de Velde C; Kjell P; Quirke P
Ann Surg Oncol; 2012 Sep; 19(9):2842-52. PubMed ID: 22526897
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]